Envveno Medical Corp cash flow statement

In fiscal 2019, Envveno Medical Corp's operations generated −$5.9m of cash; it spent $363,891 on capital projects, leaving free cash flow of −$6.3m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Envveno Medical Corp: cash flow statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019
Cash from operations	−4,202	−6,356	−5,896
Depreciation and amortisation	139	133	124
Stock-based pay	878	1,922	942
Capital spending	11	12	364
Free cash flow	−4,213	−6,368	−6,260
Free cash flow after stock pay	−5,092	−8,291	−7,202
Shares issued	1,292	—	—

US$ thousands unless shown otherwise. Fiscal quarters.

Envveno Medical Corp: cash flow statement, quarterly
Quarter	2018 Q1Mar 2018	2018 Q2Jun 2018	2018 Q3Sept 2018	2018 Q4Dec 2018	2019 Q1Mar 2019	2019 Q2Jun 2019	2019 Q3Sept 2019	2019 Q4Dec 2019
Cash from operations	−1,625	−1,541	−1,745	−1,445	−1,494	−1,430	−1,350	−1,623
Depreciation and amortisation	33	33	33	34	22	27	35	39
Stock-based pay	137	1,122	388	276	104	447	194	197
Capital spending	—	—	—	4	2	177	172	13
Free cash flow	—	—	—	−1,449	−1,495	−1,607	−1,522	−1,636
Free cash flow after stock pay	—	—	—	−1,724	−1,600	−2,054	−1,716	−1,833

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Envveno Medical Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Envveno Medical Corp.